NCT01259739

Brief Summary

The purpose of this study is to characterize the potential improvement of cocoa flavanols on exercise capacity in highly trained cyclist. A placebo-controlled double-blinded randomized control study will be performed in 13 highly trained cyclist (crossover design). Participants will perform a baseline exercise testing on an ergometer. They will receive either a flavanol-poor or flavanol rich cocoa drink twice daily for one week before a second and third exercise testing is performed. The order of drinks is randomized and balanced (high-flavanol--\>low-flavanol drink or low-flavanol drink--\>high-flavanol drink)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 13, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 14, 2010

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2013

Completed
Last Updated

November 8, 2013

Status Verified

November 1, 2013

Enrollment Period

2.9 years

First QC Date

December 13, 2010

Last Update Submit

November 7, 2013

Conditions

Keywords

trained cyclistsno medicationsno diseasesnon-smokers

Outcome Measures

Primary Outcomes (1)

  • Cardiopulmonary exercise capacity (time to complete time trail, lactate anaerobic threshold, cardio-pulmonary exercise capacity

    7 days

Secondary Outcomes (1)

  • Endothelial function

    7 days

Study Arms (2)

Flavanol rich cocoa

EXPERIMENTAL

(596 mg), dissolved in water, twice daily intervention

Other: Cocoa

flavanol poor cocoa drink

EXPERIMENTAL

( 13mg) dissolved in water, twice daily intervention

Other: Cocoa

Interventions

CocoaOTHER

dissolved in water twice-daily intervention

Flavanol rich cocoaflavanol poor cocoa drink

Eligibility Criteria

Age20 Years - 36 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • highly trained cyclists (VO2 peak \> 50 ml/kg bodyweight)
  • refrain from cocoa ingestion during trial
  • training continued throughout testing
  • \> 20 years
  • male

You may not qualify if:

  • \> 36 years
  • poor endothelial function
  • acute infection
  • any chronic heart or pulmonary disease
  • arrhythmias
  • acute or chronic renal failure
  • smokers
  • cardio-vascular risk factors : diabetes mellitus, hypertension, hyperlipidemia
  • intake of nutrition supplements (l-arginine, creatinine)
  • intake of WADA listed doping substances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heinrich-Heine-University

Düsseldorf, North Rhine-Westphalia, 40225, Germany

Location

Related Publications (1)

  • Rassaf T, Totzeck M, Hendgen-Cotta UB, Shiva S, Heusch G, Kelm M. Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res. 2014 May 9;114(10):1601-10. doi: 10.1161/CIRCRESAHA.114.303822. Epub 2014 Mar 18.

Related Links

MeSH Terms

Interventions

Chocolate

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Tienush Rassaf, MD, PhD

    Heinrich Heine University Düsseldorf, NRW, Germany

    PRINCIPAL INVESTIGATOR
  • Malte Kelm, MD, PhD

    Heinrich Heine University Düsseldorf, NRW, Germany

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Tienush Rassaf, MD, PhD

Study Record Dates

First Submitted

December 13, 2010

First Posted

December 14, 2010

Study Start

November 1, 2010

Primary Completion

October 1, 2013

Study Completion

November 1, 2013

Last Updated

November 8, 2013

Record last verified: 2013-11

Locations